Impact of perioperative dexmedetomidine treatment on 1-year mortality in patients undergoing orthotopic heart transplantation
Perioperative dexmedetomidine treatment appears to be safe regarding 1-yr mortality in patients undergoing orthotopic heart transplantation.
Authors
- Hug Aubin (ORCID: https://orcid.org/0000-0001-9289-8927)
- Giovanna Lurati Buse (ORCID: https://orcid.org/0000-0002-8076-5737)
- Sebastian Roth (ORCID: https://orcid.org/0000-0001-6830-2839)
- Carolin Torregroza (ORCID: https://orcid.org/0000-0002-5737-480X)
- Alexandra Stroda (ORCID: https://orcid.org/0000-0003-0882-2474)
- René M’Pembele (ORCID: https://orcid.org/0009-0007-7499-3331)
- Artur Lichtenberg (ORCID: https://orcid.org/0000-0001-8580-6369)
- Udo Boeken (ORCID: https://orcid.org/0000-0001-8128-9659)
- Ragnar Huhn (ORCID: https://orcid.org/0000-0002-3114-7190)
- Carla Luisa ENDREß
Institutions
- Düsseldorf University Hospital (DE)
- Kerckhoff Klinik (DE)
- Amsterdam University Medical Centers (NL)
- Heinrich Heine University Düsseldorf (DE)
- University of Amsterdam (NL)
Publication Details
- Journal
- BJA Open
- Published
- 2025-03-14
- DOI
- https://doi.org/10.1016/j.bjao.2025.100389
- Primary Topic
- Anesthesia and Sedative Agents
- Type
- article
- Field-Weighted Citation Impact
- 0.00